CLYM's cash position deteriorated substantially from $87.2M to $35.7M while the company reduced net losses, creating a critical liquidity timeline concern for this development-stage biotech.
The dramatic cash decline of nearly 60% combined with expanded risk factor language around capital access signals potential funding pressures ahead. While the company showed improved operational efficiency with reduced net losses, the cash burn trajectory suggests CLYM may need to secure additional financing or strategic partnerships within the next 12-18 months to sustain operations.
CLYM's balance sheet shows concerning liquidity trends with cash and equivalents falling sharply to $35.7M while current liabilities increased to $7.0M, though the company demonstrated better cost control with net losses improving to $59.9M from $73.9M. Total assets declined across the board, and stockholders' equity dropped to $160.5M, reflecting the ongoing cash consumption. The financial picture suggests a biotech company burning through capital while making progress on operational efficiency, but facing an accelerating need for external funding.
Cash declined 59.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Current liabilities surged 41.6% — significant near-term obligations; verify ability to meet short-term debt.
Liabilities grew 37% — significant increase in debt or obligations, assess impact on financial flexibility.
Current assets declined 31.7% — monitor working capital adequacy and short-term liquidity.
Equity decreased 24.3% — buybacks or losses reducing book value, monitor solvency ratios.
Total assets contracted 22.8% — asset sales, write-downs, or balance sheet optimization underway.
Net income grew 19% — bottom-line growth signals improving overall business health.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →